Latest filing published 23 Mar 2026 for 宣泰医药.
李方立: trading record in brief
This profile gathers the share dealings of 李方立 in 宣泰医药, where the filings describe the role as chief executive. Over a trading history stretching from 4 March 2026 to 23 March 2026, the count stands at 2 filings.
No open-market sale appears; the market trades are 2 purchases worth €6,706. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
Most recently, on 23 March 2026, the filings show an open-market purchase worth €4,226 in 宣泰医药. Every figure here comes from the filings published by SSE / SZSE (CSRC) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to 李方立
Open company profiles for insider transactions, fundamentals and analyst consensus when available.